These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 32012897)

  • 21. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease.
    Danielyan L; Schäfer R; von Ameln-Mayerhofer A; Bernhard F; Verleysdonk S; Buadze M; Lourhmati A; Klopfer T; Schaumann F; Schmid B; Koehle C; Proksch B; Weissert R; Reichardt HM; van den Brandt J; Buniatian GH; Schwab M; Gleiter CH; Frey WH
    Rejuvenation Res; 2011 Feb; 14(1):3-16. PubMed ID: 21291297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat.
    Blandini F; Cova L; Armentero MT; Zennaro E; Levandis G; Bossolasco P; Calzarossa C; Mellone M; Giuseppe B; Deliliers GL; Polli E; Nappi G; Silani V
    Cell Transplant; 2010; 19(2):203-17. PubMed ID: 19906332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson's disease.
    Migliore MM; Ortiz R; Dye S; Campbell RB; Amiji MM; Waszczak BL
    Neuroscience; 2014 Aug; 274():11-23. PubMed ID: 24845869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of Wharton's jelly-derived Mesenchymal Stromal Cells on behaviors, EEG changes and NGF-1 in rat model of the Parkinson's disease.
    Jalali MS; Saki G; Farbood Y; Azandeh SS; Mansouri E; Ghasemi Dehcheshmeh M; Sarkaki A
    J Chem Neuroanat; 2021 Apr; 113():101921. PubMed ID: 33600923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of porcine umbilical cord matrix mesenchymal stem cells in a mouse model of Parkinson's disease.
    Kang EJ; Lee YH; Kim MJ; Lee YM; Kumar BM; Jeon BG; Ock SA; Kim HJ; Rho GJ
    J Tissue Eng Regen Med; 2013 Mar; 7(3):169-82. PubMed ID: 22081626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neural metabolite changes in corpus striatum after rat multipotent mesenchymal stem cells transplanted in hemiparkinsonian rats by magnetic resonance spectroscopy.
    Fu W; Zheng Z; Zhuang W; Chen D; Wang X; Sun X; Wang X
    Int J Neurosci; 2013 Dec; 123(12):883-91. PubMed ID: 23768098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
    Somoza R; Juri C; Baes M; Wyneken U; Rubio FJ
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1530-40. PubMed ID: 20542127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?
    Vilaça-Faria H; Salgado AJ; Teixeira FG
    Cells; 2019 Feb; 8(2):. PubMed ID: 30717429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BDNF-modified human umbilical cord mesenchymal stem cells-derived dopaminergic-like neurons improve rotation behavior of Parkinson's disease rats through neuroprotection and anti-neuroinflammation.
    Jiang Z; Wang J; Sun G; Feng M
    Mol Cell Neurosci; 2022 Dec; 123():103784. PubMed ID: 36228967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine].
    Meng JL; Ma YY; Luo HY; Kong SZ; He YW; Dong BC; Wu SH; He M
    Sheng Li Xue Bao; 2008 Jun; 60(3):369-74. PubMed ID: 18560728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model.
    Ni W; Zhou J; Ling Y; Lu X; Niu D; Zeng Y; Qiu Y; Si Y; Wang J; Zhang W; Wang Z; Hu J
    Brain Res; 2022 Sep; 1790():147978. PubMed ID: 35690143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noradrenaline neuron degeneration contributes to motor impairments and development of L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
    Shin E; Rogers JT; Devoto P; Björklund A; Carta M
    Exp Neurol; 2014 Jul; 257():25-38. PubMed ID: 24747357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model.
    Sampaio TB; Pinton S; da Rocha JT; Gai BM; Nogueira CW
    Eur J Pharmacol; 2017 Jan; 795():28-35. PubMed ID: 27915043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human adipose-derived mesenchymal stem cells improve motor functions and are neuroprotective in the 6-hydroxydopamine-rat model for Parkinson's disease when cultured in monolayer cultures but suppress hippocampal neurogenesis and hippocampal memory function when cultured in spheroids.
    Berg J; Roch M; Altschüler J; Winter C; Schwerk A; Kurtz A; Steiner B
    Stem Cell Rev Rep; 2015 Feb; 11(1):133-49. PubMed ID: 25120226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
    Fleming SM; Delville Y; Schallert T
    Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
    Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
    Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesias.
    Paillé V; Henry V; Lescaudron L; Brachet P; Damier P
    Mov Disord; 2007 Mar; 22(4):533-9. PubMed ID: 17230470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heat shock protein 60 affects behavioral improvement in a rat model of Parkinson's disease grafted with human umbilical cord mesenchymal stem cell-derived dopaminergic-like neurons.
    Zhao C; Li H; Zhao XJ; Liu ZX; Zhou P; Liu Y; Feng MJ
    Neurochem Res; 2016 Jun; 41(6):1238-49. PubMed ID: 26758268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.
    Choi DH; Kim JH; Kim SM; Kang K; Han DW; Lee J
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.